A Rutgers study has found that a specific gene in cancerous prostate tumors indicates when patients are at high-risk for the cancer to spread, suggesting that targeting this gene can help patients live longer. The study, which was published in the journal Nature Communications and lead by Antonina Mitrofanova, pictured, an assistant professor at Rutgers School of Health Professions and a research member of Rutgers Cancer Institute of New Jersey, identified the NSD2 gene through a computer algorithm developed to determine which cancer genes that spread in a mouse model were most relevant to humans. The researchers were able to turn off the gene in the mice tumor cells, which significantly decreased the cancers spread. More.
|
